Atypical hemolytic uremic syndrome: a nationwide Colombian pediatric series
Background Atypical hemolytic uremic syndrome (aHUS) is a rare complement-mediated kidney disease with genetic predisposition and represents up to 10% of pediatric hemolytic uremic syndrome (HUS) cases. Few studies have evaluated aHUS in Latin American population. We studied a Colombian pediatric co...
- Autores:
-
Espitaleta, Zilac
Domínguez-Vargas, Alex
Villamizar-Martínez, Johanna
Carrascal-Guzmán, Martha
Guerrero-Tinoco, Gustavo
Silva-Diaz, Diana
Baquero, Richard
Pinto-Bernal, Claudia
González-Chaparro, Luz
Rojas-Rosas, Luisa
Amado-Niño, Pilar
Castillo-Arteaga, Mariángel
Alvarez-Gomez, Yeferson
Arguello-Muñoz, Laura
Morales-Camacho, William
León-Guerra, Oscar
Egea, Eduardo
Galeano-Rodríguez, Ricardo
Quintero-Gómez, Ana
Aroca-Martínez, Gustavo
G. Musso, Carlos
- Tipo de recurso:
- Fecha de publicación:
- 2023
- Institución:
- Universidad Simón Bolívar
- Repositorio:
- Repositorio Digital USB
- Idioma:
- eng
- OAI Identifier:
- oai:bonga.unisimon.edu.co:20.500.12442/12236
- Acceso en línea:
- https://hdl.handle.net/20.500.12442/12236
https://doi.org/10.21203/rs.3.rs-2670677/v1
https://assets.researchsquare.com/files/rs-2670677/v1/dfbb9c86-25d8-44c0-99f6-db8a73a8af70.pdf?c=1681156974
- Palabra clave:
- Pediatric Atypical hemolytic uremic syndrome
Thrombotic microangiopathy
Extrarenal manifestations
- Rights
- restrictedAccess
- License
- Attribution-NonCommercial-NoDerivatives 4.0 Internacional
id |
USIMONBOL2_5e368a0d31071211f702a6d052fb24f0 |
---|---|
oai_identifier_str |
oai:bonga.unisimon.edu.co:20.500.12442/12236 |
network_acronym_str |
USIMONBOL2 |
network_name_str |
Repositorio Digital USB |
repository_id_str |
|
dc.title.eng.fl_str_mv |
Atypical hemolytic uremic syndrome: a nationwide Colombian pediatric series |
title |
Atypical hemolytic uremic syndrome: a nationwide Colombian pediatric series |
spellingShingle |
Atypical hemolytic uremic syndrome: a nationwide Colombian pediatric series Pediatric Atypical hemolytic uremic syndrome Thrombotic microangiopathy Extrarenal manifestations |
title_short |
Atypical hemolytic uremic syndrome: a nationwide Colombian pediatric series |
title_full |
Atypical hemolytic uremic syndrome: a nationwide Colombian pediatric series |
title_fullStr |
Atypical hemolytic uremic syndrome: a nationwide Colombian pediatric series |
title_full_unstemmed |
Atypical hemolytic uremic syndrome: a nationwide Colombian pediatric series |
title_sort |
Atypical hemolytic uremic syndrome: a nationwide Colombian pediatric series |
dc.creator.fl_str_mv |
Espitaleta, Zilac Domínguez-Vargas, Alex Villamizar-Martínez, Johanna Carrascal-Guzmán, Martha Guerrero-Tinoco, Gustavo Silva-Diaz, Diana Baquero, Richard Pinto-Bernal, Claudia González-Chaparro, Luz Rojas-Rosas, Luisa Amado-Niño, Pilar Castillo-Arteaga, Mariángel Alvarez-Gomez, Yeferson Arguello-Muñoz, Laura Morales-Camacho, William León-Guerra, Oscar Egea, Eduardo Galeano-Rodríguez, Ricardo Quintero-Gómez, Ana Aroca-Martínez, Gustavo G. Musso, Carlos |
dc.contributor.author.none.fl_str_mv |
Espitaleta, Zilac Domínguez-Vargas, Alex Villamizar-Martínez, Johanna Carrascal-Guzmán, Martha Guerrero-Tinoco, Gustavo Silva-Diaz, Diana Baquero, Richard Pinto-Bernal, Claudia González-Chaparro, Luz Rojas-Rosas, Luisa Amado-Niño, Pilar Castillo-Arteaga, Mariángel Alvarez-Gomez, Yeferson Arguello-Muñoz, Laura Morales-Camacho, William León-Guerra, Oscar Egea, Eduardo Galeano-Rodríguez, Ricardo Quintero-Gómez, Ana Aroca-Martínez, Gustavo G. Musso, Carlos |
dc.subject.eng.fl_str_mv |
Pediatric Atypical hemolytic uremic syndrome Thrombotic microangiopathy Extrarenal manifestations |
topic |
Pediatric Atypical hemolytic uremic syndrome Thrombotic microangiopathy Extrarenal manifestations |
description |
Background Atypical hemolytic uremic syndrome (aHUS) is a rare complement-mediated kidney disease with genetic predisposition and represents up to 10% of pediatric hemolytic uremic syndrome (HUS) cases. Few studies have evaluated aHUS in Latin American population. We studied a Colombian pediatric cohort to delineate disease presentation and outcomes. Methods A multicenter cohort of 27 Colombian children with aHUS were enrolled between 2010 to 2019. Patients were grouped by age at onset. Clinical features were compared using analysis of variance (ANOVA) and Fisher exact tests. Renal biopsy was performed on six patients who were suspected of having other renal diseases before aHUS diagnosis. Results Most patients were male (70%). The onset of aHUS occurred frequently before age 4 years (60%) and followed gastroenteritis as the main triggering event (52%). Age groups were comparable in clinical presentation, disease severity, treatment, and outcomes. Pulmonary involvement (67%) was the main extrarenal manifestation. A higher frequency was observed in the 1–7 age group (p = 0.01). Renal biopsies were as follows: three had membranoproliferative glomerulonephritis (MPGN) type I, one MPGN type III, one C3-glomerulonephritis, and one rapidly progressive glomerulonephritis. Genetic screening was available in five patients and identified 2xCFHR5, 2xMCP, and 1xADAMTS-13/THBD mutations. A total of 15 relapses were seen, of which 8 (72%) occurred in the 1–7 age group. The renal outcome was not significantly different regardless of age group. Conclusion In our cohort, we observed a relatively high frequency of extrarenal involvement at first presentation represented by pulmonary manifestations. The renal prognosis at initial presentation was worse than in previous reports. |
publishDate |
2023 |
dc.date.accessioned.none.fl_str_mv |
2023-04-17T15:05:02Z |
dc.date.available.none.fl_str_mv |
2023-04-17T15:05:02Z |
dc.date.issued.none.fl_str_mv |
2023 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
dc.type.driver.eng.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.spa.spa.fl_str_mv |
Artículo científico |
dc.identifier.issn.none.fl_str_mv |
26935015 |
dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/20.500.12442/12236 |
dc.identifier.doi.eng.fl_str_mv |
https://doi.org/10.21203/rs.3.rs-2670677/v1 |
dc.identifier.url.eng.fl_str_mv |
https://assets.researchsquare.com/files/rs-2670677/v1/dfbb9c86-25d8-44c0-99f6-db8a73a8af70.pdf?c=1681156974 |
identifier_str_mv |
26935015 |
url |
https://hdl.handle.net/20.500.12442/12236 https://doi.org/10.21203/rs.3.rs-2670677/v1 https://assets.researchsquare.com/files/rs-2670677/v1/dfbb9c86-25d8-44c0-99f6-db8a73a8af70.pdf?c=1681156974 |
dc.language.iso.eng.fl_str_mv |
eng |
language |
eng |
dc.rights.*.fl_str_mv |
Attribution-NonCommercial-NoDerivatives 4.0 Internacional Attribution-NonCommercial-NoDerivatives 4.0 Internacional |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_16ec |
dc.rights.uri.*.fl_str_mv |
http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.rights.accessrights.spa.fl_str_mv |
info:eu-repo/semantics/restrictedAccess |
rights_invalid_str_mv |
Attribution-NonCommercial-NoDerivatives 4.0 Internacional http://creativecommons.org/licenses/by-nc-nd/4.0/ http://purl.org/coar/access_right/c_16ec |
eu_rights_str_mv |
restrictedAccess |
dc.format.mimetype.spa.fl_str_mv |
pdf |
dc.publisher.eng.fl_str_mv |
Research Square Company |
dc.source.eng.fl_str_mv |
Research square |
dc.source.none.fl_str_mv |
Vol XX, No X, (2023) |
institution |
Universidad Simón Bolívar |
bitstream.url.fl_str_mv |
https://bonga.unisimon.edu.co/bitstreams/64472cb8-828d-4686-8d22-02f0417d414c/download https://bonga.unisimon.edu.co/bitstreams/9087ddb1-0a45-4712-8767-ebfe8aa4034d/download https://bonga.unisimon.edu.co/bitstreams/447aecff-22e3-4406-92fa-e0e177ab6cc2/download https://bonga.unisimon.edu.co/bitstreams/d2271dfb-9c91-4e8c-978b-8b525b2adaed/download https://bonga.unisimon.edu.co/bitstreams/47c72ccd-1c45-4115-b5c7-419fcf64bf45/download https://bonga.unisimon.edu.co/bitstreams/49414f1d-c81c-4208-969c-f336b62f61d1/download https://bonga.unisimon.edu.co/bitstreams/8581fcb3-c9fd-4a95-988b-1cacfc27df70/download |
bitstream.checksum.fl_str_mv |
cefc83e2c70fd1ea5a3e19e904fc7fe5 4460e5956bc1d1639be9ae6146a50347 733bec43a0bf5ade4d97db708e29b185 76c7cf2141c1fbecf02e85b382b30c22 76c7cf2141c1fbecf02e85b382b30c22 3162894a46fba71b1d89e38a50a7de27 3162894a46fba71b1d89e38a50a7de27 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio Digital Universidad Simón Bolívar |
repository.mail.fl_str_mv |
repositorio.digital@unisimon.edu.co |
_version_ |
1814076153400393728 |
spelling |
Espitaleta, Zilac444ae19d-81a9-4686-821f-ce6dc31b4fa9Domínguez-Vargas, Alexd3599d9a-0024-4ac5-9bfb-269da6854041Villamizar-Martínez, Johannaa5f88b5d-ef85-4c88-adf1-3ed79815f06fCarrascal-Guzmán, Martha46d213c4-f883-4162-98c6-f9a7d207de90Guerrero-Tinoco, Gustavoe6a1bc89-7e66-4ef2-adf8-565f4f628a2cSilva-Diaz, Diana445c32d6-1b5e-4d82-a94a-02571455e84aBaquero, Richardf874b826-d369-4fef-bd6f-a4413c70eed8Pinto-Bernal, Claudia12294b48-a846-4349-8ba0-a4eeb6690943González-Chaparro, Luzc09d89d1-358a-4172-a6fe-b14baaf05de3Rojas-Rosas, Luisa9ad94c36-73b7-4543-a885-f33fd500070cAmado-Niño, Pilar7779f5d1-b64d-4617-a9ef-59838910841dCastillo-Arteaga, Mariángelb92d9444-809a-4f10-89cf-f87db11c48dbAlvarez-Gomez, Yeferson02da9b32-10d9-426a-b693-f52da41d7e25Arguello-Muñoz, Laura0050c1b0-3a6d-43d6-9799-a3c9ebd306eeMorales-Camacho, Williamd774107d-1494-4cf6-8256-b024419c4010León-Guerra, Oscar4c12995f-baa1-4715-9b9f-87a37653e9d5Egea, Eduardo4f89b318-81b2-4eff-af87-ea8302a1d867Galeano-Rodríguez, Ricardo170974ec-67ec-4d48-bcaf-f8e55032f508Quintero-Gómez, Ana6937bd81-287f-445f-bd17-8f5bd68cffe4Aroca-Martínez, Gustavoef65933f-3af8-4323-9a75-9d00de17e70aG. Musso, Carlos1558dfd1-c0d4-4a2e-bf43-38a3a1d8ce112023-04-17T15:05:02Z2023-04-17T15:05:02Z202326935015https://hdl.handle.net/20.500.12442/12236https://doi.org/10.21203/rs.3.rs-2670677/v1https://assets.researchsquare.com/files/rs-2670677/v1/dfbb9c86-25d8-44c0-99f6-db8a73a8af70.pdf?c=1681156974Background Atypical hemolytic uremic syndrome (aHUS) is a rare complement-mediated kidney disease with genetic predisposition and represents up to 10% of pediatric hemolytic uremic syndrome (HUS) cases. Few studies have evaluated aHUS in Latin American population. We studied a Colombian pediatric cohort to delineate disease presentation and outcomes. Methods A multicenter cohort of 27 Colombian children with aHUS were enrolled between 2010 to 2019. Patients were grouped by age at onset. Clinical features were compared using analysis of variance (ANOVA) and Fisher exact tests. Renal biopsy was performed on six patients who were suspected of having other renal diseases before aHUS diagnosis. Results Most patients were male (70%). The onset of aHUS occurred frequently before age 4 years (60%) and followed gastroenteritis as the main triggering event (52%). Age groups were comparable in clinical presentation, disease severity, treatment, and outcomes. Pulmonary involvement (67%) was the main extrarenal manifestation. A higher frequency was observed in the 1–7 age group (p = 0.01). Renal biopsies were as follows: three had membranoproliferative glomerulonephritis (MPGN) type I, one MPGN type III, one C3-glomerulonephritis, and one rapidly progressive glomerulonephritis. Genetic screening was available in five patients and identified 2xCFHR5, 2xMCP, and 1xADAMTS-13/THBD mutations. A total of 15 relapses were seen, of which 8 (72%) occurred in the 1–7 age group. The renal outcome was not significantly different regardless of age group. Conclusion In our cohort, we observed a relatively high frequency of extrarenal involvement at first presentation represented by pulmonary manifestations. The renal prognosis at initial presentation was worse than in previous reports.pdfengResearch Square CompanyAttribution-NonCommercial-NoDerivatives 4.0 InternacionalAttribution-NonCommercial-NoDerivatives 4.0 Internacionalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/restrictedAccesshttp://purl.org/coar/access_right/c_16ecResearch squareVol XX, No X, (2023)Pediatric Atypical hemolytic uremic syndromeThrombotic microangiopathyExtrarenal manifestationsAtypical hemolytic uremic syndrome: a nationwide Colombian pediatric seriesinfo:eu-repo/semantics/articleArtículo científicohttp://purl.org/coar/resource_type/c_2df8fbb1Zipfel PF, Heinen S, Skerka C. Thrombotic microangiopathies: new insights and new challenges. Curr Opin Nephrol Hypertens. 2010;19(4):372-378. doi:10.1097/MNH.0b013e32833aff4aNoris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med. 2009;361(17):1676-1687. doi:10.1056/NEJMra0902814Kurosawa S, Stearns-Kurosawa DJ. Complement, thrombotic microangiopathy, and disseminated intravascular coagulation. J intensive care. 2014;2(1):65. doi:10.1186/s40560-014-0061-4Raina R, Krishnappa V, Blaha T, et al. file:///C:/Users/Alex Dominguez/Desktop/raina2018.pdf. Ther Apher Dial. 2019;23(1):4-21. doi:10.1111/1744-9987.12763Noris M, Caprioli J, Bresin E, et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol. 2010;5(10):1844-1859. doi:10.2215/CJN.02210310Dragon-Durey M-A, Loirat C, Cloarec S, et al. Anti-Factor H autoantibodies associated with the atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2005;16(2):555-563. doi:10.1681/ASN.2004050380Bu F, Maga T, Meyer NC, et al. Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2014;25(1):55-64. doi:10.1681/ASN.2013050453Caprioli J, Noris M, Brioschi S, et al. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood. 2006;108(4):1267-1279. doi:10.1182/blood-2005-10- 007252Raina R, Krishnappa V, Blaha T, et al. Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment. Ther Apher Dial. 2019;23(1):4-21. doi:10.1111/1744-9987.12763Caprioli J, Bettinaglio P, Zipfel PF, et al. The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. J Am Soc Nephrol. 2001;12(2):297-307. doi:10.1681/ASN.V122297Fremeaux-Bacchi V, Fakhouri F, Garnier A, et al. Genetics and outcome of atypical hemolytic uremic syndrome: A nationwide french series comparing children and adults. Clin J Am Soc Nephrol. 2013;8(4):554-562. doi:10.2215/CJN.04760512Kavanagh D, Richards A, Noris M, et al. Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome. Mol Immunol. 2008;45(1):95-105. doi:10.1016/j.molimm.2007.05.004Goicoechea de Jorge E, Harris CL, Esparza-Gordillo J, et al. Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc Natl Acad Sci U S A. 2007;104(1):240-245. doi:10.1073/pnas.0603420103Frémeaux-Bacchi V, Miller EC, Liszewski MK, et al. Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood. 2008;112(13):4948-4952. doi:10.1182/blood-2008-01-133702Delvaeye M, Noris M, De Vriese A, et al. Thrombomodulin Mutations in Atypical Hemolytic–Uremic Syndrome. N Engl J Med. 2009;361(4):345-357. doi:10.1056/NEJMoa0810739Mills MC, Rahal C. A scientometric review of genome-wide association studies. Commun Biol. 2019;2(1):9. doi:10.1038/s42003-018-0261-xJiménez-Kaufmann A, Chong AY, Cortés A, et al. Imputation Performance in Latin American Populations: Improving Rare Variants Representation With the Inclusion of Native American Genomes. Front Genet. 2022;12(January):1-11. doi:10.3389/fgene.2021.719791Homburger JR, Moreno-Estrada A, Gignoux CR, et al. Genomic Insights into the Ancestry and Demographic History of South America. PLoS Genet. 2015;11(12):1-26. doi:10.1371/journal.pgen.1005602Conley AB, Rishishwar L, Norris ET, et al. A comparative analysis of genetic ancestry and admixture in the Colombian populations of chocó and Medellín. G3 Genes, Genomes, Genet. 2017;7(10):3435-3447. doi:10.1534/g3.117.1118Geerdink LM, Westra D, Van Wijk JAE, et al. Atypical hemolytic uremic syndrome in children: Complement mutations and clinical characteristics. Pediatr Nephrol. 2012;27(8):1283-1291. doi:10.1007/s00467-012-2131-yRondeau E, Cataland SR, Al-Dakkak I, Miller B, Webb NJA, Landau D. Eculizumab Safety: Five-Year Experience From the Global Atypical Hemolytic Uremic Syndrome Registry. Kidney Int Reports. 2019;4(11):1568-1576. doi:10.1016/j.ekir.2019.07.016Brodsky RA. Eculizumab and aHUS: to stop or not. Blood. 2021;137(18):2419-2420. doi:10.1182/blood.2020010234R Core Team. R: A Language and Environment for Statistical Computing. Published online 2015.Fremeaux-Bacchi V, Fakhouri F, Garnier A, et al. Genetics and outcome of atypical hemolytic uremic syndrome: A nationwide french series comparing children and adults. Clin J Am Soc Nephrol. 2013;8(4):554-562. doi:10.2215/CJN.04760512Zhao J, Wu H, Khosravi M, et al. Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. PLoS Genet. 2011;7(5):e1002079. doi:10.1371/journal.pgen.1002079Manenti L, Gnappi E, Vaglio A, et al. Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature. Nephrol Dial Transplant. 2013;28(9):2246-2259. doi:10.1093/ndt/gft220Formeck C, Swiatecka-Urban A. Extra-renal manifestations of atypical hemolytic uremic syndrome. Pediatr Nephrol. 2019;34(8):1337-1348. doi:10.1007/s00467-018-4039-7Schaefer F, Ardissino G, Ariceta G, et al. Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome. Kidney Int. 2018;94(2):408-418. doi:10.1016/j.kint.2018.02.029Hofer J, Rosales A, Fischer C, Giner T. Extra-renal manifestations of complement-mediated thrombotic microangiopathies. Front Pediatr. 2014;2:97. doi:10.3389/fped.2014.00097Cabarcas-Barbosa O, Aroca-Martínez G, Musso CG, et al. Atypical hemolytic uremic syndrome in the Colombian Caribbean: its particular characteristics. Int Urol Nephrol. 2022;54(6):1323-1330. doi:10.1007/s11255-021-03011- 5Formeck C, Swiatecka-Urban A. Extra-renal manifestations of atypical hemolytic uremic syndrome. Pediatr Nephrol. 2019;34(8):1337-1348. doi:10.1007/s00467-018-4039-7Brackman D, Sartz L, Leh S, et al. Thrombotic microangiopathy mimicking membranoproliferative glomerulonephritis. Nephrol Dial Transplant. 2011;26(10):3399-3403. doi:10.1093/ndt/gfr422Siegler RL, Brewer ED, Pysher TJ. Hemolytic uremic syndrome associated with glomerular disease. Am J Kidney Dis. 1989;13(2):144-147. doi:10.1016/s0272-6386(89)80133-7Dische FE, Culliford EJ, Parsons V. Haemolytic uraemic syndrome and idiopathic membranous glomerulonephritis. Br Med J. 1978;1(6120):1112-1113. doi:10.1136/bmj.1.6120.1112Jha V, Murthy MSN, Kohli HS, et al. Secondary Membranoproliferative Glomerulonephritis Due to Hemolytic Uremic Syndrome: An Unusual Presentation. Ren Fail. 1998;20(6):845-850. doi:10.3109/08860229809045182Licht C, Fremeaux-Bacchi V. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis. Thromb Haemost. 2009;101(02):271-278. doi:10.1160/TH08-09-0575Barbour TD, Ruseva MM, Pickering MC. Update on C3 glomerulonephritis. Nephrol Dial Transplant. 2016;31(5):717-725. doi:10.1093/ndt/gfu317Noris M, Donadelli R, Remuzzi G. Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulonephritis. Pediatr Nephrol. Published online 2018:1- 13. doi:10.1007/s00467-018-3989-0Józsi M, Barlow PN, Meri S. Editorial: Function and Dysfunction of Complement Factor H. Front Immunol. 2022;12. doi:10.3389/fimmu.2021.831044Zhang Y, Ghiringhelli Borsa N, Shao D, et al. Factor H Autoantibodies and Complement-Mediated Diseases. Front Immunol. 2020;11. doi:10.3389/fimmu.2020.607211Gatault P, Brachet G, Ternant D, et al. Therapeutic drug monitoring of eculizumab: Rationale for an individualized dosing schedule. MAbs. 2015;7(6):1205-1211. doi:10.1080/19420862.2015.1086049Greenbaum LA, Fila M, Ardissino G, et al. Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome. Kidney Int. 2016;89(3):701-711. doi:10.1016/j.kint.2015.11.026Pablo Córdoba J, Mariel Contreras K, Larrarte C, et al. Síndrome hemolítico urémico atípico, revisión de la literatura y documento de consenso. Enfoque diagnóstico y tratamiento. Rev Colomb Nefrol. 2015;2(1):19-40.ORIGINALPDF.pdfPDF.pdfPDFapplication/pdf5432742https://bonga.unisimon.edu.co/bitstreams/64472cb8-828d-4686-8d22-02f0417d414c/downloadcefc83e2c70fd1ea5a3e19e904fc7fe5MD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8805https://bonga.unisimon.edu.co/bitstreams/9087ddb1-0a45-4712-8767-ebfe8aa4034d/download4460e5956bc1d1639be9ae6146a50347MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-8381https://bonga.unisimon.edu.co/bitstreams/447aecff-22e3-4406-92fa-e0e177ab6cc2/download733bec43a0bf5ade4d97db708e29b185MD53TEXTAtypical_hemolytic_uremic_syndrome.pdf.txtAtypical_hemolytic_uremic_syndrome.pdf.txtExtracted texttext/plain38948https://bonga.unisimon.edu.co/bitstreams/d2271dfb-9c91-4e8c-978b-8b525b2adaed/download76c7cf2141c1fbecf02e85b382b30c22MD54PDF.pdf.txtPDF.pdf.txtExtracted texttext/plain38948https://bonga.unisimon.edu.co/bitstreams/47c72ccd-1c45-4115-b5c7-419fcf64bf45/download76c7cf2141c1fbecf02e85b382b30c22MD56THUMBNAILAtypical_hemolytic_uremic_syndrome.pdf.jpgAtypical_hemolytic_uremic_syndrome.pdf.jpgGenerated Thumbnailimage/jpeg4426https://bonga.unisimon.edu.co/bitstreams/49414f1d-c81c-4208-969c-f336b62f61d1/download3162894a46fba71b1d89e38a50a7de27MD55PDF.pdf.jpgPDF.pdf.jpgGenerated Thumbnailimage/jpeg4426https://bonga.unisimon.edu.co/bitstreams/8581fcb3-c9fd-4a95-988b-1cacfc27df70/download3162894a46fba71b1d89e38a50a7de27MD5720.500.12442/12236oai:bonga.unisimon.edu.co:20.500.12442/122362024-08-14 21:54:03.281http://creativecommons.org/licenses/by-nc-nd/4.0/Attribution-NonCommercial-NoDerivatives 4.0 Internacionalopen.accesshttps://bonga.unisimon.edu.coRepositorio Digital Universidad Simón Bolívarrepositorio.digital@unisimon.edu.coPGEgcmVsPSJsaWNlbnNlIiBocmVmPSJodHRwOi8vY3JlYXRpdmVjb21tb25zLm9yZy9saWNlbnNlcy9ieS1uYy80LjAvIj48aW1nIGFsdD0iTGljZW5jaWEgQ3JlYXRpdmUgQ29tbW9ucyIgc3R5bGU9ImJvcmRlci13aWR0aDowO3dpZHRoOjEwMHB4OyIgc3JjPSJodHRwczovL2kuY3JlYXRpdmVjb21tb25zLm9yZy9sL2J5LW5jLzQuMC84OHgzMS5wbmciIC8+PC9hPjxici8+RXN0YSBvYnJhIGVzdMOhIGJham8gdW5hIDxhIHJlbD0ibGljZW5zZSIgaHJlZj0iaHR0cDovL2NyZWF0aXZlY29tbW9ucy5vcmcvbGljZW5zZXMvYnktbmMvNC4wLyI+TGljZW5jaWEgQ3JlYXRpdmUgQ29tbW9ucyBBdHJpYnVjacOzbi1Ob0NvbWVyY2lhbCA0LjAgSW50ZXJuYWNpb25hbDwvYT4u |